Found: 26
Select item for more details and to access through your institution.
ADC histograms predict response to anti-angiogenic therapy in patients with recurrent high-grade glioma.
- Published in:
- Neuroradiology, 2011, v. 53, n. 4, p. 291, doi. 10.1007/s00234-010-0808-0
- By:
- Publication type:
- Article
Changes in Brain Energy and Membrane Metabolism in Glioblastoma following Chemoradiation.
- Published in:
- Current Oncology, 2021, v. 28, n. 6, p. 5041, doi. 10.3390/curroncol28060424
- By:
- Publication type:
- Article
Nuclear Overhauser Enhancement Imaging of Glioblastoma at 7 Tesla: Region Specific Correlation with Apparent Diffusion Coefficient and Histology.
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0121220
- By:
- Publication type:
- Article
Quantification of Tumor Vessels in Glioblastoma Patients Using Time-of-Flight Angiography at 7 Tesla: A Feasibility Study.
- Published in:
- PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0110727
- By:
- Publication type:
- Article
An Intra-Individual Comparison of MRI, [<sup>18</sup>F]-FET and [<sup>18</sup>F]-FLT PET in Patients with High-Grade Gliomas.
- Published in:
- PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0095830
- By:
- Publication type:
- Article
Quantification of regional functional improvement of infarcted myocardium after primary PTCA by contrast-enhanced magnetic resonance imaging.
- Published in:
- Journal of Magnetic Resonance Imaging, 2009, v. 29, n. 2, p. 298, doi. 10.1002/jmri.21498
- By:
- Publication type:
- Article
Peritumoral ADC Values Correlate with the MGMT Methylation Status in Patients with Glioblastoma.
- Published in:
- Cancers, 2023, v. 15, n. 5, p. 1384, doi. 10.3390/cancers15051384
- By:
- Publication type:
- Article
MRI Response Assessment in Glioblastoma Patients Treated with Dendritic-Cell-Based Immunotherapy.
- Published in:
- Cancers, 2022, v. 14, n. 6, p. 1579, doi. 10.3390/cancers14061579
- By:
- Publication type:
- Article
Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial.
- Published in:
- Cancers, 2018, v. 10, n. 10, p. 372, doi. 10.3390/cancers10100372
- By:
- Publication type:
- Article
Validation of diffusion MRI phenotypes for predicting response to bevacizumab in recurrent glioblastoma: post-hoc analysis of the EORTC-26101 trial.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 11, p. 1667, doi. 10.1093/neuonc/noaa120
- By:
- Publication type:
- Article
Temporal muscle thickness is an independent prognostic marker in patients with progressive glioblastoma: translational imaging analysis of the EORTC 26101 trial.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 12, p. 1587, doi. 10.1093/neuonc/noz131
- By:
- Publication type:
- Article
Radiologic progression of glioblastoma under therapy--an exploratory analysis of AVAglio.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 4, p. 557, doi. 10.1093/neuonc/nox162
- By:
- Publication type:
- Article
Diagnostic challenges in meningioma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 12, p. 1588, doi. 10.1093/neuonc/nox101
- By:
- Publication type:
- Article
Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 12, p. 1673, doi. 10.1093/neuonc/now122
- By:
- Publication type:
- Article
Amino acid positron emission tomography to monitor chemotherapy response and predict seizure control and progression-free survival in WHO grade II gliomas.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 5, p. 744, doi. 10.1093/neuonc/nov282
- By:
- Publication type:
- Article
Relative cerebral blood volume is a potential predictive imaging biomarker of bevacizumab efficacy in recurrent glioblastoma.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 8, p. 1139, doi. 10.1093/neuonc/nov028
- By:
- Publication type:
- Article
Pseudoprogression in patients with glioblastoma: clinical relevance despite low incidence.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 1, p. 151, doi. 10.1093/neuonc/nou129
- By:
- Publication type:
- Article
A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07).
- Published in:
- Neuro-Oncology, 2014, v. 16, n. 1, p. 92, doi. 10.1093/neuonc/not161
- By:
- Publication type:
- Article
Response to “Reply to [18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma” by Hutterer et al.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 7, p. 814, doi. 10.1093/neuonc/not081
- By:
- Publication type:
- Article
[18F]-fluoro-ethyl-l-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 3, p. 341, doi. 10.1093/neuonc/nos300
- By:
- Publication type:
- Article
ADC textural features in patients with single brain metastases improve clinical risk models.
- Published in:
- Clinical & Experimental Metastasis, 2022, v. 39, n. 3, p. 459, doi. 10.1007/s10585-022-10160-z
- By:
- Publication type:
- Article
Whole brain radiotherapy combined with intrathecal liposomal cytarabine for leptomeningeal metastasis—a safety analysis and validation of the EANO-ESMO classification.
- Published in:
- Strahlentherapie und Onkologie, 2022, v. 198, n. 5, p. 475, doi. 10.1007/s00066-022-01910-9
- By:
- Publication type:
- Article
O-(2-<sup>18</sup>F-Fluoroethyl)-L-Tyrosine PET Predicts Failure of Antiangiogenic Treatment in Patients with Recurrent High-Grade Glioma.
- Published in:
- Journal of Nuclear Medicine, 2011, v. 52, n. 6, p. 856, doi. 10.2967/jnumed.110.086645
- By:
- Publication type:
- Article
Prevention of Oxidative Damage in Spinal Cord Ischemia Upon Aortic Surgery: First-In-Human Results of Shock Wave Therapy Prove Safety and Feasibility.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Somatostatin receptor subtype expression and radiomics from DWI-MRI represent SUV of [68Ga]Ga-DOTATOC PET in patients with meningioma.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 164, n. 3, p. 711, doi. 10.1007/s11060-023-04414-3
- By:
- Publication type:
- Article
Towards more Diversity in Neuro-oncology Leadership—the DivINe Initiative.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 12, p. 2302, doi. 10.1093/neuonc/noad157
- By:
- Publication type:
- Article